Buy Good Quality Baricitinib 1187594-09-7 with a minimum purity of 99% We supply high quality Baricitinib (CAS 1187594-09-7), in stock, factory directly supply to clients, lower prices, more competitiveness.
What is the Baricitinib ?
Baricitinib is , while it's Molecular Formula is C16H17N7O2S. Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising treatment for rheumatoid arthritis.
What is the CAS number for Baricitinib ?
The CAS number of Baricitinib is 1187594-09-7.
More information of Baricitinib 1187594-09-7 are:
|
Synonyms |
INCB 028050;LY 3009104;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile; |
|
CAS?Number |
1187594-09-7 |
|
Molecular Formula |
C16H17N7O2S |
|
Molecular Weight |
371.423 |
|
Density |
1.6±0.1 g/cm3 |
|
HS CODE |
29350090 |
|
PSA |
128.94000 |
|
LogP |
2.11438 |
|
Pka |
11.66±0.50(Predicted) |
What is Baricitinib (1187594-09-7) used for?
Baricitinib (1187594-09-7), approved by the FDA for two inflammatory disorders, rheumatoid arthritis and alopecia areata, selectively inhibits Janus kinase 1 (IC50?= 5.9 nM) and 2 (5.7 nM), over 3 (0.56 μM).1?It thereby blocks JAK/STAT signaling, reducing cytokine release and suppressing the innate and adaptive immune systems.1,2?Was recently shown to significantly improve COVID-19 symptoms in a preliminary human trial, presumably through suppression of the cytokine release syndrome (“cytokine storm”) induced by SARS-CoV-2 infection.3
Articles related to Baricitinib:
|
Article |
Source |
|
AN IMPROVED PROCESS FOR THE PREPARATION OF BARICITINIB |
- , (2021/04/01) |
|
Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib |
Dasari,Seelam,Jayachandra,Vadali,Yerva,Tondepu,Gadakar , p. 1569 - 1574 (2019/12/28) |
How to get the best price on Baricitinib?
Shijiazhuang Hengsikai Chemical Import and Export Co.,Ltd is a quality supplier and manufacturer of Baricitinib . You can buy high quality, low price Baricitinib 1187594-09-7 here. Contact us.